Alcohol Use Disorder: Etiology, Neurobiology & Recovery Pathways

Alcohol Use Disorder (AUD) is a chronic relapsing brain disorder characterized by impaired control over drinking, preoccupation with alcohol, and continued use despite adverse consequences (DSM-5: ≥2 of 11 criteria in 12 months).

Multifactorial Etiology

  • Genetic (40–60% heritability): ADH/ALDH variants (Asian flush protective), GABRA2, CHRM2, KCNJ6, DRD2, OPRM1, polygenic scores.
  • Neurobiological: Alcohol → ↑GABA (inhibition), ↓glutamate (excitation), ↑dopamine (reward: NAc/VTA), ↑endorphins, ↑serotonin, ↓CRF (acute). Chronic: neuroadaptation → tolerance, withdrawal (hyperexcitability), allostasis (new set-point).
  • Psychological: Comorbid anxiety, depression, PTSD, trauma → self-medication. Impulsivity, sensation-seeking, low distress tolerance.
  • Environmental: Early exposure, parental modeling, peer norms, stress, availability, marketing, socioeconomic disadvantage.
  • Developmental: Adolescent onset → worse prognosis (prefrontal cortex maturation disrupted).

Treatment (Evidence-Based)

  • Medications (FDA-approved): Naltrexone (oral/XR-injectable — reduces heavy drinking), Acamprosate (abstinence maintenance), Disulfiram (aversion — supervised use). Off-label: topiramate, gabapentin, baclofen, varenicline.
  • Psychotherapy: CBT, MET, CRA, DBT, mindfulness-based, contingency management.
  • Mutual Help: AA, SMART Recovery, LifeRing, Women for Sobriety — improve outcomes when combined with professional care.
  • Levels of Care: Outpatient → IOP → Residential → Medically managed withdrawal (CIWA-Ar protocol, benzodiazepines).
  • Integrated Care: Treat comorbid MH/SUD simultaneously.

Recovery Is Possible

Remission rates at 1 year: ~25–35% with treatment; higher with combined modalities. Long-term recovery common. Relapse is part of the trajectory — not failure. Stigma reduction and early screening (AUDIT-C in primary care) save lives.

Drug Addiction - Related Articles